Vocal Biomarkers Market to Hit $5.1 Billion by 2028
Brandessence Market Research expects the worldwide vocal biomarkers market to grow from $1.9 billion in 2021 to more than $5.1 billion by 2028, growing at a compounded annual rate of 15.45 percent.
The research firm attributes growth to rising demand for less-invasive tools to diagnose and treat some psychological, neurological, and cardiovascular disorders, including Parkinson's disease, Alzheimer's disease, schizophrenia, cognitive impairment, multiple sclerosis, rheumatoid arthritis, and mental health and emotional issues. Vocal biomarkers are used generally for the detection of illnesses using the features of speech based on the idea that some ailments affect motor controls and therefore modify speech patterns.<.p>
Brandessence also expects vocal biomarkers to see a significant application in the detection of lies by defense organizations and security agencies when they are questioning criminals.
The report identified Beyond, Boston Technology, Microtest Health, Verbal, Sonde Health, IBM, Audio Profiling, and Cogito as leading vendors in the space.